epirubicin has been researched along with Multiple Primary Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, H; Ando, K; Furuya, D; Kawada, H; Kawai, H; Ogawa, Y; Suzuki, R | 1 |
| Adhi, MI; Kashif, S; Muhammad, K; Siyal, N | 1 |
| Adhoute, X; Bayle, O; Beaurain, P; Bourlière, M; Bronowicki, JP; Cassagneau, P; Castellani, P; Monnet, O; Muller, C; Oules, V; Pénaranda, G; Perrier, H; Pietri, O; Pol, B; Raoul, JL | 1 |
| Champagne, C; Gaillot-Petit, N; Guilbert, P; Lamberth, F; Looten-Vieren, L; Nguyen, TD | 1 |
| Hirakawa, K; Ishikawa, T; Kashiwagi, S; Kato, Y; Kawajiri, H; Nakata, B; Noda, S; Onoda, N; Takashima, T | 1 |
| Clemens, MR; Darb-Esfahani, S; Denkert, C; Diebold, K; Dietrich, K; Eidtmann, H; Hanusch, C; Henschen, S; Hoffmann, G; Holms, F; Huober, J; Just, M; Loibl, S; Schrader, I; Solbach, C; Tesch, H; Tiemann, K; Untch, M; von Minckwitz, G | 1 |
| Carinelli, S; Maggioni, A; Peiretti, M; Rosenberg, P; Zanagnolo, V | 1 |
| Benekli, M; Buyukberber, S; Coskun, U; Tonyali, O; Tufan, G | 1 |
| Fu, J; Leng, H; Liang, L; Liu, YL; Xing, W; Zhang, HW | 1 |
| Bramwell, V; Crump, M; Levine, M; Pritchard, K; Shepherd, L; Tu, D | 1 |
| Canda, AE; Kirkali, Z; Mungan, MU; Tuzel, E; Yorukoglu, K | 1 |
| Brausi, M; Carpentier, P; de Reijke, TM; Hall, RR; Kurth, KH; Landsoght, KE; Sylvester, RJ; van de Beek, K | 1 |
| Esfahani, F; Mehraban, D | 1 |
| Chen, RC; Chen, WT; Chiang, LC; Lii, JM; Tu, HY | 1 |
| Calpena, R; Cansado Martínez, P; Lacueva Gómez, FJ; Martínez Banaclocha, N; Merck, B; Pérez Ramos, M | 1 |
| Akaza, H; Hinotsu, S; Kotake, T; Ohashi, Y | 1 |
| Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
2 review(s) available for epirubicin and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor: a case report and review of literature.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Ifosfamide; Neoplasms, Multiple Primary; Ovarian Neoplasms; Prolactin; Sarcoma; Sertoli-Leydig Cell Tumor; Testosterone; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2012 |
Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Female; Humans; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Risk; Time Factors; Urinary Bladder Neoplasms | 1999 |
1 trial(s) available for epirubicin and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Disease Progression; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Survival Rate; Time Factors; Urinary Bladder Neoplasms | 2005 |
14 other study(ies) available for epirubicin and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Hepatocellular; Docetaxel; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Treatment Outcome; Tretinoin | 2020 |
Outcome of focal treatment to residual retinoblastoma after chemotherapy (Experience with Focal Treatment of Retinoblastoma).
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cryosurgery; Cyclophosphamide; Epirubicin; Female; Humans; Infant; Laser Coagulation; Male; Neoplasm, Residual; Neoplasms, Multiple Primary; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2017 |
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Contrast Media; Epirubicin; Ethiodized Oil; Female; France; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Multiple Primary; Prognosis; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2019 |
[Potential indications for helical tomotherapy in breast cancers].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Funnel Chest; Hodgkin Disease; Humans; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Obesity; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Taxoids | 2014 |
[A case of multicentric breast cancer in which an effect of neoadjuvant chemotherapy had a disparity].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasms, Multiple Primary | 2010 |
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Clinical Trials, Phase III as Topic; Cyclophosphamide; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome | 2012 |
Synchronous bilateral breast cancer in a patient with kindler syndrome.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Blister; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epidermolysis Bullosa; Epirubicin; Female; Humans; Mastectomy; Neoplasms, Multiple Primary; Periodontal Diseases; Photosensitivity Disorders; Tamoxifen; Trastuzumab | 2012 |
[Invasive ductal carcinoma and chronic lymphocytic leukemia: a unique case of collision tumor in breast].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel | 2011 |
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Leukemia; Methotrexate; Middle Aged; Neoplasms, Multiple Primary; Risk | 2003 |
Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Epirubicin; Follow-Up Studies; Humans; Male; Middle Aged; Mucous Membrane; Neoplasms, Multiple Primary; Prostatic Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms | 2004 |
Re: Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase III Trial (30906).
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Clinical Trials, Phase III as Topic; Epirubicin; Humans; Mathematical Computing; Multicenter Studies as Topic; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Reproducibility of Results; Sample Size; Urinary Bladder Neoplasms | 2005 |
Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Follow-Up Studies; Hemangioma, Cavernous; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Retreatment; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Mastectomy, Simple; Middle Aged; Neoplasms, Multiple Primary; Phyllodes Tumor; Radiotherapy, Adjuvant; Remission Induction | 2006 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |